Breaking News Instant updates and real-time market news.

MS

Morgan Stanley

$46.64

0.07 (0.15%)

, GS

Goldman Sachs

$225.58

1.25 (0.56%)

06:20
10/02/18
10/02
06:20
10/02/18
06:20

Fed could broaden definition of 'big bank,' WSJ reports

The Federal Reserve could broaden the number of banks receiving regulatory relief from Trump-appointed officials under an initiative that changes how it defines a big bank, The Wall Street Journal reports. The changes could lead to lower regulatory costs for some big banks, including Capital One (COF), PNC (PNC) and U.S. Bancorp (USB), but it is less clear if the changes will help banks the Fed considers "systemically important" such as Goldman Sachs (GS) and Citi (C). Other publicly traded companies in the space include Bank of America (BAC), JPMorgan (JPM), Morgan Stanley (MS), and Wells Fargo (WFC). Reference Link

MS

Morgan Stanley

$46.64

0.07 (0.15%)

GS

Goldman Sachs

$225.58

1.25 (0.56%)

JPM

JPMorgan

$113.55

0.71 (0.63%)

BAC

Bank of America

$29.66

0.19 (0.64%)

USB

U.S. Bancorp

$52.83

0.02 (0.04%)

WFC

Wells Fargo

$52.26

-0.3 (-0.57%)

C

Citi

$71.95

0.2 (0.28%)

COF

Capital One

$94.92

-0.015 (-0.02%)

PNC

PNC Financial

$136.03

-0.16 (-0.12%)

  • 02

    Oct

  • 02

    Oct

  • 02

    Oct

  • 02

    Oct

  • 04

    Oct

  • 12

    Oct

  • 12

    Oct

  • 12

    Oct

  • 16

    Oct

  • 17

    Oct

  • 19

    Oct

  • 21

    Oct

  • 23

    Oct

  • 14

    Jan

  • 16

    Jan

  • 26

    Feb

  • 12

    Apr

  • 12

    Apr

  • 15

    Apr

  • 13

    Jul

  • 13

    Jul

  • 17

    Jul

  • 12

    Oct

  • 16

    Oct

MS Morgan Stanley
$46.64

0.07 (0.15%)

10/02/18
HSBC
10/02/18
DOWNGRADE
HSBC
Hold
Morgan Stanley downgraded to Hold from Buy at HSBC
09/25/18
WOLF
09/25/18
INITIATION
Target $61
WOLF
Outperform
Morgan Stanley initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Morgan Stanley with an Outperform and $61 price target.
09/20/18
RBCM
09/20/18
NO CHANGE
Target $60
RBCM
Outperform
Morgan Stanley EPS ests lowered at RBC Capital on declining advisory fees
RBC Capital analyst Gerard Cassidy kept his Outperform rating and $60 price target on Morgan Stanley but lowered his FY18 EPS view to $4.70 from $4.88 and FY19 view to $5.15 from $5.47. The analyst says his new targets assume advisory fees declining 2% and Equity and Debt Capital Market segments fees decline of 0.9% and 2.3% respectively, even though he sees equity trading revenues rising 5.8%. Cassidy further expects Morgan Stanley's investment management revenue to fall "modestly" on anticipated funds outflow from "money market mutual fund sweeps".
07/19/18
07/19/18
UPGRADE

Market Perform
Morgan Stanley upgraded to Market Perform on more balanced risk/reward at Bernstein
As previously reported, Bernstein analyst Christian Bolu upgraded Morgan Stanley to Market Perform from Underperform saying that while he still sees some risks, his concerns are now better reflected in the stock given price underperformance over recent months. Wealth management still a risk, but now a better understood risk, he contends.
GS Goldman Sachs
$225.58

1.25 (0.56%)

08/15/18
VERT
08/15/18
NO CHANGE
VERT
Sell
Goldman involvement with Tesla 'doesn't mean anything,' says Vertical Research
Vertical Research analyst Gordon Johnson said Goldman Sachs (GS) being confirmed as a financial advisor to Tesla's (TSLA) proposed go-private offer "does not mean anything" beyond the "superficial optics" of the carmaker being able to "use Goldman's prestigious name to lend credence to the deal." Goldman is "in it for M&A fees" and agreeing to be an advisor is "not based on any inherent understanding of Tesla's value proposition, nor is it based on Goldman's confidence in Tesla's legal situation with respect to its significant issues surrounding disclosures and SEC involvement," according to Johnson, who maintains a Sell rating on Tesla shares.
09/18/18
MSCO
09/18/18
NO CHANGE
Target $70
MSCO
Overweight
TD Ameritrade most logical buyer if E-Trade opts for sale, says Morgan Stanley
Morgan Stanley analyst Michael Cyprys noted that E-Trade (ETFC) in mid-2016 gave itself an 18- to 24-month deadline to improve core metrics or consider strategic options and that self-imposed strategic review deadline is nearing. The company plans to give an update on its review on the Q3 earnings call, likely in mid-October, he said. Of the potential acquirers identified in the media, Cyprys believes TD Ameritrade (AMTD) could possibly achieve the greatest accretion and therefore pay the most, making it the most logical buyer if E-Trade's board opts to pursue a sale. Charles Schwab (SCHW) is another potential acquirer, though he thinks such a combination could make less strategic sense. Goldman Sachs (GS) has said it is looking to build out its consumer business through mass market, but Cyprys concludes it is not the best bidder given regulatory hurdles, low synergies and low expected EPS accretion, he tells investors. The analyst keeps an Overweight rating and $70 price target on E-Trade shares.
09/19/18
OPCO
09/19/18
NO CHANGE
OPCO
Outperform
U.S. banks 'in very good shape,' says Oppenheimer, favorites include BofA, Citi
Oppenheimer analyst Chris Kotowski tells investors in a research note that the U.S. banking group is on solid footing with balance sheets less risky than at any time over the last 33 years the firm covered the group and says his favorite bank stocks are Outperform-rated Bank of America (BAC), Citi (C), CIT (CIT) and Goldman Sachs (GS). However, Kotowski notes that banks are trading at an average relative P/E of just ~66% relative to the S&P 500 and returning to a historical avg valuation of 73%-80% range would imply over a thousand basis points of outperformance by the group. In his view, the U.S. banks are, on the whole, in "very good" shape.
09/25/18
WOLF
09/25/18
INITIATION
Target $290
WOLF
Outperform
Goldman Sachs initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Goldman Sachs with an Outperform and $290 price target.
JPM JPMorgan
$113.55

0.71 (0.63%)

08/21/18
JEFF
08/21/18
NO CHANGE
JEFF
Jefferies says JPMorgan service could impact discount broker new account growth
Following news that JPMorgan (JPM) will soon be offering a digital brokerage service that offers 100 free trades, Jefferies analyst Daniel Fannon said he does not view this as much a threat to existing clients at TD Ameritrade (AMTD), E-Trade (ETFC) or Charles Schwab (SCHW), but he does think it may have an impact on new account growth over time. He thinks TD Ameritrade and E-Trade will take a "wait and see approach" and that Schwab is most likely to be looked to for a competitor response. Both TD Ameritrade and E-Trade are materially more dependent on trading as a percent of total revenue than Charles Schwab, added Fannon.
09/25/18
WOLF
09/25/18
INITIATION
Target $140
WOLF
Outperform
JPMorgan initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated JPMorgan with an Outperform and $140 price target.
08/22/18
DBAB
08/22/18
NO CHANGE
DBAB
JPMorgan mobile launch a catalyst for industry consolidation, says Deutsche
Deutsche Bank analyst Brian Bedell believes JPMorgan's (JPM) reported rollout of online trading to its 47M customers next week should be a catalyst for online broker industry consolidation. The analyst believes the news supports his TD Ameritrade (AMTD), E-Trade (ETFC) merger scenario thesis. He points out that his model already includes "substantial" trade price compression.
08/22/18
SBSH
08/22/18
NO CHANGE
SBSH
JPMorgan mobile trading platform 'another salvo' on online brokers, says Citi
JPMorgan's (JPM) reported zero cost mobile trading service to be launched next week is "another salvo" in the war on broker dealers' fundamentals, Citi analyst William Katz tells investors in a research note. JPMorgan's move further underscores the commoditization risk to pricing across the retail broker dealer complex, particularly online brokers, the analyst adds. Further, he believes the new product adds an additional degree of difficulty to pricing a potential E-Trade (ETFC) acquisition or other retail broker deals. The analyst's work suggests negative 3% and negative 1% earnings risk to TD Ameritrade (AMTD) and Charles Schwab (SCHW), respectively. However, Katz believes much of the negativity is already priced into Ameritrade following yesterday's selloff. For Schwab, he believes continued pressure on Investor Services presents further downside risk in the stock from here.
BAC Bank of America
$29.66

0.19 (0.64%)

07/09/18
GSCO
07/09/18
NO CHANGE
GSCO
Bank of America, Morgan Stanley top ideas into Q2 earnings season, says Goldman Sachs
Goldman Sachs analyst Richard Ramsden expects Bank of America (BAC) and Morgan Stanley (MS) to beat consensus estimates in Q2. The analyst argues that both appear best positioned, while he sees risk for U.S. Bancorp (USB) and JPMorgan (JPM). Ramsden highlights Bank of America given the material valuation dislocation that looks to support the stock over time. Additionally, the analyst expects an expense and NII beat for Morgan Stanley.
07/17/18
BARD
07/17/18
NO CHANGE
Target $30
BARD
Neutral
Baird would be buyers of Bank of America on weakness
Baird analyst David George said he would remain a buyer of Bank of America shares on any weakness, stating that its operating leverage was impressive in Q2 and should continue along with solid execution. George maintained his Neutral rating and $30 price target on Bank of America shares.
09/25/18
WOLF
09/25/18
INITIATION
Target $40
WOLF
Outperform
Bank of America initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Bank of America with an Outperform and $40 price target.
USB U.S. Bancorp
$52.83

0.02 (0.04%)

07/18/18
SPHN
07/18/18
NO CHANGE
Target $105
SPHN
Overweight
Comerica could be viewed as acquisition target, says Stephens
Stephens analyst Terry McEvoy raised his capital payout forecast for Comerica (CMA) for the second half of this year and for 2019 as he expects the company will announce an increase in the dividend and larger buyback plan after its board meets on July 24. Additionally, McEvoy thinks Comerica could be viewed as an takeover target once BB&T (BBT) and U.S. Bancorp (USB) are in a position to acquire banks. Stating that he likes both its fundamental and strategic outlook, McEvoy keeps an Overweight rating and $105 price target on Comerica shares.
08/21/18
RBCM
08/21/18
NO CHANGE
Target $61
RBCM
Outperform
U.S. Bancorp capital deployment 'deliberate' and prudent, says RBC Capital
RBC Capital analyst Gerard Cassidy kept his Outperform rating and $61 price target on U.S. Bancorp after his NDR meetings with its management that highlighted the company's focus on growing its core deposits. The analyst further notes that while the bank expects a technology-driven industry consolidation, its investments have been targeted at technology initiatives and its approach to M&A has been "deliberate and cautious". Cassidy adds that the company's spending mix shifting from defensive areas like compliance and infrastructure and toward more growth-oriented areas like digital migration and real-time payment.
09/14/18
SPHN
09/14/18
NO CHANGE
SPHN
Subprime lenders weakness may be opportunity, says Stephens
Stephens analyst Vincent Caintic attributes weakness in shares of subprime consumer lenders to news that U.S. Bancorp (USB) is re-entering the small dollar, high yield lending business after Fifth Third (FITB) re-entered two months ago. However, he views the OCC's push for banks to offer small dollar loans as a positive for online lenders and notes that the recent bank announcements are for loans yielding 40%-70%, which competes against products from Regional Management (RM) and World Acceptance (WRLD) but should not impact online lenders. Subprime online lenders include Enova (ENVA) and Elevate Credit (ELVT). Other publicly traded companies in the FinTech space include LendingClub (LC) and On Deck Capital (ONDK).
WFC Wells Fargo
$52.26

-0.3 (-0.57%)

09/17/18
EDJN
09/17/18
UPGRADE
EDJN
Buy
Wells Fargo upgraded to Buy from Hold at Edward Jones (Friday)
09/28/18
UBSW
09/28/18
NO CHANGE
Target $63
UBSW
Buy
Wells Fargo app download data suggests no momentum slowdown, says UBS
UBS analyst Saul Martinez reassessed Wells Fargo client engagement and employee sentiment and found that app download data was encouraging and showed no slowdown in momentum. Employee sentiment, however, showed a material weakening. The analyst said meaningful improvements in earnings power and profitability require revenue to stabilize and the recent share weakness may be due to concerns that business momentum and top line growth will continue to lag. Martinez maintained his Buy rating and $63 price target on Wells Fargo shares.
09/25/18
WOLF
09/25/18
INITIATION
Target $71
WOLF
Outperform
Wells Fargo initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Wells Fargo with an Outperform and $71 price target.
09/12/18
JPMS
09/12/18
NO CHANGE
JPMS
Underweight
Reported OCC rejection would be negative for Wells, says JPMorgan
According to Reuters, Office of the Comptroller of the Currency regulators have rejected Wells Fargo's plan to repay its auto customers who were pushed to buy unnecessary auto insurance, JPMorgan analyst Vivek Juneja tells investors in a research note. This rejection would be a negative for Wells as it may be required to spend more and take more time to satisfy regulators, the analyst writes. He also views the news negatively overall for the bank's ongoing regulatory issues. Juneja reiterates an Underweight rating on shares of Wells Fargo.
C Citi
$71.95

0.2 (0.28%)

07/27/18
RHCO
07/27/18
NO CHANGE
Target $240
RHCO
Buy
MasterCard price target raised to $240 from $215 at SunTrust
SunTrust analyst Andrew Jeffrey raised his price target on MasterCard to $240 and kept his Buy rating, saying the company is demonstrating expansion of global market share while posting a 14% Q2 volume growth. The analyst adds that while MasterCard has a higher valuation than PayPal (PYPL) and Visa (V) - a 10% relative EBITDA premium - it is justified and may even be too narrow given its superior growth sustainability and margin upside.
08/28/18
WELS
08/28/18
NO CHANGE
Target $100
WELS
Outperform
Citi to benefit from potential U.S.-Mexico trade deal, says Wells Fargo
Wells Fargo analyst Mike Mayo believes Citi could gain more than other large U.S. banks from a U.S.-Mexico trade deal given its ownership of the second largest bank in Mexico, Citibanamex. In his view, Citi's stock had been hurt on perceptions of the U.S. relationship with Mexico. At a minimum, any new trade deal could reflect the absence of a negative and, on the upside, new potential growth opportunities, he contends. Mayo reiterates an Outperform rating and $100 price target on the shares.
09/25/18
WOLF
09/25/18
INITIATION
Target $91
WOLF
Outperform
Citi initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Citi with an Outperform and $91 price target.
COF Capital One
$94.92

-0.015 (-0.02%)

07/27/18
JPMS
07/27/18
NO CHANGE
Target $39
JPMS
Overweight
Synchrony 'substantially oversold' on Walmart news, says JPMorgan
JPMorgan analyst Richard Shane believes Synchrony Financial (SYF) shares have been "substantially oversold" relative to the fundamental impact to the business from Walmart's (WMT) decision to go with Capital One (COF). The analyst reiterates an Overweight rating on Synchrony and recommends buying the stock at current levels. He estimates a $625M reduction of 2020 net income to common shareholders, or 17c per share in earnings. Shane lowered his price target for Synchrony to $39 from $41 as a result. He believes, however, that the stock will continue to trade at a discount to these levels until there is more clarity about a strategic outcome.
07/27/18
07/27/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. MATTEL UPGRADED ON TAKEOVER POSSIBILITY: DA Davidson analyst Linda Bolton Weiser upgraded Mattel (MAT) to Neutral from Underperform and raised her price target to $14 from $12. The analyst noted that while the company underperformed in Q2 as she expected, due to the hard 2017 comparisons driven by last year's Cars 3 release and the impact from the Toys R Us liquidation, investor belief that the company could be sold is supporting the stock. Weiser adds that as long as Ynon Kreiz is at the helm, Mattel's elevated valuation could persist. INTEL GETS MULTIPLE DOWNGRADES AFTER EARNINGS: Citi analyst Christopher Danely downgraded Intel (INTC) to Neutral from Buy and lowered his price target for the shares to $50 from $64. The analyst said he sees a "host of margin headwinds coming" and calls the company's rollout of 10 nanometer a "debacle." He believes Intel's valuation multiple will remain under pressure. BofA Merrill Lynch downgraded Intel to Neutral from Buy and lowered its price target to $56 from $62 following the Q2 report. Analyst Vivek Arya said shares will remain range bound given a deceleration in FY19 earnings growth, a competitive position that is becoming tougher with next-gen 10mn product delays, higher capex from insourcing memory, and potential gross margin declines. Intel is down 8.4% in late morning trading. JPMORGAN DEFENDS SYNCHRONY: JPMorgan analyst Richard Shane believes Synchrony Financial (SYF) shares have been "substantially oversold" relative to the fundamental impact to the business from Walmart's (WMT) decision to go with Capital One (COF). The analyst reiterated an Overweight rating on Synchrony and recommended buying the stock at current levels. He estimated a $625M reduction of 2020 net income to common shareholders, or 17c per share in earnings. Shane lowered his price target for Synchrony to $39 from $41 as a result. He believes, however, that the stock will continue to trade at a discount to these levels until there is more clarity about a strategic outcome. AMAZON PRICE TARGET RAISED AT MULTIPLE FIRMS: After reporting its Q2 results, Amazon (AMZN) saw its price target raised by multiple analysts, including by Deutsche Bank analyst Lloyd Walmsley, who raised his price target for Amazon.com to $2,300. He said last night's Q2 results beat his expectations "almost across the board," and added that Amazon remains his top pick among the large cap Internet names. The analyst kept a Buy rating on the shares. Amazon shares are 1.4% higher to about $1,834 in late morning trading.
07/30/18
BARD
07/30/18
NO CHANGE
Target $102
BARD
Outperform
TSYS could have opportunity with new Walmart/Capital One deal, says Baird
Baird analyst David Koning noted Walmart (WMT) announced a deal with Capital One (COF) as the new issuer of its store credit card. The analyst said he sees a potential opportunity for TSYS (TSS) to provide the issuer processing services for this contract given its strong relationship with Capital One. He views TSYS as a good idea with its price likely to drift to roughly $100 per by year-end. Koning reiterated his Outperform rating and $102 price target on TSYS shares.
09/18/18
OPCO
09/18/18
NO CHANGE
Target $116
OPCO
Outperform
Capital One continues to be 'top idea,' says Oppenheimer
Oppenheimer analyst Dominick Gabriele maintains an Outperform rating and $116 price target on Capital One (COF), telling investors in a research note that it continues to be the firm's "top idea," as he thinks it will likely see the most near-term upside due to credit metric improvement. Gabriele also says Discover (DFS) also stands out this month due to the more decisive break in trend "from cresting to improvement in formation" and continues to recommend the stock and American Express (AXP) in addition to Capital One.
PNC PNC Financial
$136.03

-0.16 (-0.12%)

07/20/18
OPCO
07/20/18
NO CHANGE
OPCO
Perform
Wells Fargo's next few earnings reports likely to be 'choppy,' says Oppenheimer
Oppenheimer analyst Chris Kotowski maintained a Perform rating on Wells Fargo (WFC) after recent meetings with CFO John Shrewsberry. In a research note to investors, Kotowski says there was nothing that shakes his view that the next few quarterly earnings reports are likely to still be "choppy," and notes that Shewsberry "readily acknowledged" that there was much work to be done to get the consent order lifted. At the same time, the analyst contends that shares are not trading at much of a discount versus other high performing banks like JPMorgan (JPM) and PNC (PNC) and says he favors companies that have lower but rising ROTCEs that are trading near TBV, especially Citi (C), CIT (CIT) and Goldman (GS).
06/14/18
RBCM
06/14/18
NO CHANGE
Target $170
RBCM
Top Pick
PNC Financial EPS view cut at RBC Capital on reduced mortgage banking outlook
RBC Capital analyst Gerard Cassidy lowered his PNC Financial FY18 EPS view to $10.51 from $10.60 and FY19 view to $11.32 from $11.46 after the recent commentary by the management that its Q2 mortgage banking revenues are tracking to be 12% lower than in Q1. The analyst keeps his Top Pick rating and $170 price target however, saying the bank is well positioned for higher interest rates that would expand its net interest income and also has a high 42% of the total component for its non-interest income. Cassidy adds that the regulatory environment benefits could also exceed his expectations.
05/30/18
BARD
05/30/18
NO CHANGE
Target $153
BARD
Outperform
PNC Financial added as Fresh Pick at Baird
Baird analyst David George said the weakness in PNC Financial is a buying opportunity and said it screens as one of the better values among regional banks. The analyst likes the bank's competitive positioning, solid intermediate-term outlook, and its current valuation. George reiterated his Outperform rating and $153 price target on PNC Financial shares.
04/16/18
BARD
04/16/18
NO CHANGE
Target $153
BARD
Outperform
PNC Financial weakness overdone, says Baird
Baird analyst David George said PNC Financial posted a clean quarter and he would be a buyer of the shares on the post-earnings weakness. The analyst noted fees were down seasonally, but the bank posted good year-over-year growth. George maintained his Outperform rating and $153 price target on PNC Financial shares.

TODAY'S FREE FLY STORIES

PYPL

PayPal

$77.50

-2.61 (-3.26%)

07:28
10/19/18
10/19
07:28
10/19/18
07:28
Recommendations
PayPal analyst commentary  »

PayPal results keep Baird…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

AEO

American Eagle

$20.94

-0.54 (-2.51%)

07:28
10/19/18
10/19
07:28
10/19/18
07:28
Upgrade
American Eagle rating change  »

Citi upgrades American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

07:27
10/19/18
10/19
07:27
10/19/18
07:27
Initiation
Microsoft initiated  »

Microsoft initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

ROSE

Rosehill Resources

07:27
10/19/18
10/19
07:27
10/19/18
07:27
Initiation
Rosehill Resources initiated  »

Rosehill Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEAM

Atlassian

$81.96

-1.67 (-2.00%)

07:27
10/19/18
10/19
07:27
10/19/18
07:27
Recommendations
Atlassian analyst commentary  »

Atlassian weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISRG

Intuitive Surgical

$522.41

-20.44 (-3.77%)

07:26
10/19/18
10/19
07:26
10/19/18
07:26
Upgrade
Intuitive Surgical rating change  »

Intuitive Surgical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCTY

The9

$1.58

0.25 (18.80%)

07:25
10/19/18
10/19
07:25
10/19/18
07:25
Hot Stocks
Jie Qin reports 7.4% stake in The9 »

Jie Qin is a consultant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PVTL

Pivotal Software

$18.36

-0.585 (-3.09%)

07:25
10/19/18
10/19
07:25
10/19/18
07:25
Initiation
Pivotal Software initiated  »

Pivotal Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETFC

E-Trade

$48.89

-1.68 (-3.32%)

, AMTD

TD Ameritrade

$49.89

-1.03 (-2.02%)

07:24
10/19/18
10/19
07:24
10/19/18
07:24
Recommendations
E-Trade, TD Ameritrade, Charles Schwab analyst commentary  »

E-Trade news removes bull…

ETFC

E-Trade

$48.89

-1.68 (-3.32%)

AMTD

TD Ameritrade

$49.89

-1.03 (-2.02%)

SCHW

Charles Schwab

$46.70

-1.35 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

CHKP

Check Point

$110.75

-1.34 (-1.20%)

07:23
10/19/18
10/19
07:23
10/19/18
07:23
Initiation
Check Point initiated  »

Check Point initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 10

    Dec

F

Ford

$8.51

-0.255 (-2.91%)

, GM

General Motors

$31.08

-0.84 (-2.63%)

07:22
10/19/18
10/19
07:22
10/19/18
07:22
Downgrade
Ford, General Motors rating change  »

Morgan Stanley downgrades…

F

Ford

$8.51

-0.255 (-2.91%)

GM

General Motors

$31.08

-0.84 (-2.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

  • 13

    Dec

07:20
10/19/18
10/19
07:20
10/19/18
07:20
General news
FX Update: The Dollar has been choppy »

FX Update: The Dollar has…

OKE

Oneok

$66.94

-0.07 (-0.10%)

07:19
10/19/18
10/19
07:19
10/19/18
07:19
Upgrade
Oneok rating change  »

Oneok upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

GBT

Global Blood Therapeutics

$38.15

2.37 (6.62%)

07:19
10/19/18
10/19
07:19
10/19/18
07:19
Recommendations
Global Blood Therapeutics analyst commentary  »

FDA may consider…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

YARIY

Yara

$0.00

(0.00%)

07:17
10/19/18
10/19
07:17
10/19/18
07:17
Upgrade
Yara rating change  »

Yara upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOLVY

Volvo

$0.00

(0.00%)

07:17
10/19/18
10/19
07:17
10/19/18
07:17
Periodicals
Volvo CEO says doesn't expect fine from emissions probe, Bloomberg says »

Volvo CEO says emissions…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASB

Associated Banc-Corp

07:17
10/19/18
10/19
07:17
10/19/18
07:17
Downgrade
Associated Banc-Corp rating change  »

Associated Banc-Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

AXP

American Express

$102.86

-1.53 (-1.47%)

07:16
10/19/18
10/19
07:16
10/19/18
07:16
Recommendations
American Express analyst commentary  »

Oppenheimer remains a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

ECYT

Endocyte

$23.40

7.85 (50.48%)

, NVS

Novartis

$86.24

0.9 (1.05%)

07:16
10/19/18
10/19
07:16
10/19/18
07:16
Downgrade
Endocyte, Novartis rating change  »

Endocyte downgraded to…

ECYT

Endocyte

$23.40

7.85 (50.48%)

NVS

Novartis

$86.24

0.9 (1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

07:15
10/19/18
10/19
07:15
10/19/18
07:15
General news
Oil Action: Front-month WTI crude prices are up 0.7% »

Oil Action: Front-month…

AVXL

Anavex

$2.47

0.015 (0.61%)

07:14
10/19/18
10/19
07:14
10/19/18
07:14
Hot Stocks
Anavex receives FDA approval of IND for Phase 2 trial of Anavex 2-73 »

Anavex announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HOG

Harley-Davidson

$40.37

-1.29 (-3.10%)

07:14
10/19/18
10/19
07:14
10/19/18
07:14
Downgrade
Harley-Davidson rating change  »

Harley-Davidson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

WMT

Walmart

$96.19

-0.37 (-0.38%)

07:13
10/19/18
10/19
07:13
10/19/18
07:13
Recommendations
Walmart analyst commentary  »

Oppenheimer more…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 15

    Nov

CTSH

Cognizant

$73.60

-0.4 (-0.54%)

07:13
10/19/18
10/19
07:13
10/19/18
07:13
Recommendations
Cognizant analyst commentary  »

Cognizant risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 30

    Oct

  • 02

    Nov

  • 16

    Nov

QSR

Restaurant Brands

$57.16

0.08 (0.14%)

07:12
10/19/18
10/19
07:12
10/19/18
07:12
Recommendations
Restaurant Brands analyst commentary  »

Restaurant Brands'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.